https://www.asm.org/modules/mod_image_show_gk4/cache/mSphere Direct herogk-is-651.pnglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Podcast Hero Banner3gk-is-651.pnglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Microbe Online Program Plannergk-is-651.pnglink
https://www.asm.org/modules/mod_image_show_gk4/cache/AAAS Fellows Bannergk-is-651.jpglink
https://www.asm.org/modules/mod_image_show_gk4/cache/Read New JMBE Bannergk-is-651.jpglink
0 1 2 3 4
Progress bar
20-01-2017mSphere Direct
20-01-2017Podcast banner
20-01-2017AAAS Fellows
20-01-2017Read new JMBE
Become a member today!
JOIN/RENEW
Submit to an ASM Journal
SUBMIT
Attend ASM Biothreats Meeting
REGISTER

offit paul

 

Using reassortant rotaviruses, Dr. Paul Offit's laboratory determined the genetics of rotavirus neutralization phenotype and the genetics or rotavirus virulence. In addition, using vaccinia-rotavirus recombinants, they determined the immunodominant protein that elicited rotavirus-specific cytotoxic T lymphocytes. This information was used to construct bovine (strain WC3) human reassortant rotaviruses that eventually became the rotavirus vaccine, RotaTeq.

TPL_asm2013_SEARCH

91253